CIK 0001576280 · Large accelerated filer
Guardant Health, Inc.
Sign in to watch- Ticker
- GH
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454139254
- Phone
- 855-698-8887
- Business address
- 3100 HANOVER STREET, PALO ALTO, CA, 94304
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $9,739,100
- in 9 filings, $213K under 10b5-1 plans
Net −$9,739,100. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-04 | Krognes Steve E. Director | Sale | −9,294 | $132.51 | $1.2M | 10,222 |
| 2026-06-03 | Joyce Meghan V. Director | Option exercise 10b5-1 | +1,197 | $38.42 | $46K | 12,380 |
| 2026-06-03 | Joyce Meghan V. Director | Option exercise 10b5-1 | +8,803 | $38.01 | $335K | 21,183 |
| 2026-06-03 | Joyce Meghan V. Director | Sale 10b5-1 | −3,516 | $126.52 | $445K | 17,667 |
| 2026-06-03 | Joyce Meghan V. Director | Sale 10b5-1 | −5,728 | $127.11 | $728K | 11,939 |
| 2026-06-03 | Joyce Meghan V. Director | Sale 10b5-1 | −650 | $128.02 | $83K | 11,289 |
| 2026-06-03 | Joyce Meghan V. Director | Sale 10b5-1 | −106 | $129.31 | $14K | 11,183 |
| 2026-06-03 | Joyce Meghan V. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −1,197 | 7,908 | ||
| 2026-06-03 | Joyce Meghan V. Director | Option exercise · Stock Option (Right to Buy) 10b5-1 | −8,803 | 0 | ||
| 2026-05-31 | Krognes Steve E. Director | Option exercise | +154 | 19,516 | ||
| 2026-05-31 | Krognes Steve E. Director | Option exercise · Restricted Stock Units | −154 | 155 | ||
| 2026-05-28 | Hidalgo Medina Manuel Director | Sale | −1,000 | $130.06 | $130K | 639 |
| 2026-05-27 | Saia John G. Chief Legal Officer | Sale 10b5-1 | −9,994 | $125.08 | $1.3M | 35,956 |
| 2026-05-27 | Saia John G. Chief Legal Officer | Sale 10b5-1 | −6 | $126.08 | $756 | 35,950 |
| 2026-05-22 | Freeman Chris Chief Commercial Officer | Option exercise | +24,406 | $32.86 | $802K | 84,440 |
| 2026-05-22 | Freeman Chris Chief Commercial Officer | Sale | −24,406 | $118.67 | $2.9M | 60,034 |
| 2026-05-22 | Freeman Chris Chief Commercial Officer | Option exercise · Stock Option (Right to Buy) | −24,406 | 701 | ||
| 2026-05-21 | MIGNONE ROBERTO Director | Option exercise | +264 | 9,218 | ||
| 2026-05-21 | MIGNONE ROBERTO Director | Option exercise · Restricted Stock Units | −264 | 7,656 | ||
| 2026-05-20 | Hidalgo Medina Manuel Director | Option exercise | +1,000 | $32.55 | $33K | 2,889 |
Page 15 of 22 · 421 trades